Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges

SIMPLE SUMMARY: In hematologic cancers, Minimal Residual Disease (MRD) monitoring, using either molecular (PCR) or immunophenotypic (MFC) diagnostics, allows the identification of rare cancer cells, readily detectable either in the bone marrow or in the peripheral blood at very low levels, far below...

Descripción completa

Detalles Bibliográficos
Autores principales: Riva, Giovanni, Nasillo, Vincenzo, Ottomano, Anna Maria, Bergonzini, Giuliano, Paolini, Ambra, Forghieri, Fabio, Lusenti, Beatrice, Barozzi, Patrizia, Lagreca, Ivana, Fiorcari, Stefania, Martinelli, Silvia, Maffei, Rossana, Marasca, Roberto, Potenza, Leonardo, Comoli, Patrizia, Manfredini, Rossella, Tagliafico, Enrico, Trenti, Tommaso, Luppi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470441/
https://www.ncbi.nlm.nih.gov/pubmed/34572809
http://dx.doi.org/10.3390/cancers13184582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470441/
https://www.ncbi.nlm.nih.gov/pubmed/34572809
http://dx.doi.org/10.3390/cancers13184582

Ejemplares similares